- Home
- Clinical Trials
Premature Ejaculation Studies Sydney DH 001
Premature Ejaculation Study
Darlinghurst Sydney
Do you experience premature ejaculation – often within a minute of sexual activity?
If you have been dealing with premature ejaculation since your earliest sexual experiences, you may be eligible to take part in a clinical research study investigating a new on-demand treatment option.
This study is exploring whether a fast-acting investigational medication can increase the time to ejaculation, improve sexual satisfaction and reduce the distressing or frustrated feelings that often accompany LPE.
By taking part, you may access a potential new treatment, contribute to advancing men’s health research, and receive care and support from experienced medical professionals
Description
What to expect
Study details
Ages
18 and 65 years old
Duration
Approximately 4.5 months, and involves up to 5 scheduled clinic visits and 3 phone visits
Compensation
Participants will be compensated for their time and travel
Eligibility Criteria
You may qualify for this study if you:
- Are between 18 and 65 years old
- Are sexually active
- Have experienced premature ejaculation (typically within 1 minute) from your first sexual experiences
- Are in a stable heterosexual relationship for at least 6 months
Other eligibility criteria apply. A member of our team will determine if this study is a good fit for you.
Locations
Description
Premature Ejaculation is one of the most common male sexual health conditions, affecting an estimated 1 in 3 men at some point in their lives. For some, this is a lifelong experience - referred to as Lifelong Premature Ejaculation. Where ejaculation occurs within one minute of vaginal penetration, beginning with a man’s very first sexual encounters.
For many men, premature ejaculation can lead to feelings of frustration, embarrassment, or emotional distress, especially when it impacts their confidence, relationships, or sense of control during intimacy. These challenges are real, and they are more common than many realise.
While treatments do exist, options like daily medications or SSRIs are not always practical for everyone. They may cause unwanted side effects and often aren’t effective when taken on-demand. That’s why research into new, fast-acting treatment approaches is so important – to offer men more choice, greater control and better support for their sexual and emotional wellbeing.
This clinical study is evaluating an investigational on-demand oral tablet designed to support men living with Lifelong Premature Ejaculation. The treatment aims to delay ejaculation, improve control and sexual satisfaction, and reduce emotional distress associated with the condition.
Researchers hope it may offer a new option for men seeking relief without the drawbacks of long-term medications. This study is an important step toward expanding treatment choices and improving quality of life for those affected.
What to expect
Participants in this study will be asked to take a sublingual tablet placed under the tongue – either the investigational medication or a placebo – approximately 15 minutes before vaginal penetration during sexual activity.
Throughout the study, participants will use a secure mobile eDiary to confidentially log key information about their sexual experiences, including the time of medication intake and intercourse.
In addition to at-home tracking, participants will attend regular clinic visits for health assessments, safety monitoring, and to complete questionnaires about their experience and overall well-being.
If eligible, participants will complete two 4-week treatment periods - one receiving the investigational medication and the other a placebo - in a randomized order, with a 4-week break (washout period) in between. Every participant will receive both the study medication and a placebo over the course of the study.
After both phases are complete, researchers will carefully review all collected information to evaluate the potential effects of the treatment.
Why join this clinical research study?
· Gain early access to a new potential treatment at no cost
· Contribute to research for men with lifelong premature ejaculation
· Receive health checks and advice from our professional medical team
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.